Measuring Alterations of DNA in Human Blood

University of Rochester

Status: Completed

Conditions: Neoplasms

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00178308

URCC 1702

Details and patient eligibility

About

The purpose of this research is to evaluate an automated, laser-based technique for measuring DNA damge resulting from radiation. We want to use controlled exposure on cancer patients to help develop a measurement to test people who may have been accidentally exposed to radiation.

Sex: All

Ages: 21 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Male or female, age 21 to 70 years old.
• Patient undergoing with anti-neoplastic agent(s) known to have genotoxic activity (e.g., cyclophosphamide, 5-FU, cisplatin, Ara-C.
• X-irradiation may be considered, so long as a substantial fraction of red marrow is exposed (e.g., femur or chest/trunk region);
• treatment could be ongoing therapy or initial therapy.